Formes neurologiques de la maladie de Lyme

Réseau Sentinelles. Série temporelle Incidence maladie de Lyme [Internet]. Disponible sur : www.sentiweb.fr/france/fr/maladie de Lyme. Rupprecht, 2008, The pathogenesis of lyme neuroborreliosis: from infection to inflammation, Mol Med, 14, 205, 10.2119/2007-00091.Rupprecht Mygland, 2010, EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis, Eur J Neurol, 17, 8, 10.1111/j.1468-1331.2009.02862.x Hansen, 1992, The clinical and epidemiological profile of Lyme neuroborreliosis in Denmark 1985–1990. A prospective study of 187 patients with Borrelia burgdorferi specific intrathecal antibody production, Brain, 115, 399, 10.1093/brain/115.2.399 Oschmann, 1998, Stages and syndromes of neuroborreliosis, J Neurol, 245, 262, 10.1007/s004150050216 Figoni, 2019, Lyme borreliosis and other tick-borne diseases. Guidelines from the French Scientific Societies (I): prevention, epidemiology, diagnosis, Med Mal Infect, 49, 318, 10.1016/j.medmal.2019.04.381 Bannwarth, 1941, Chronische lymphocytare Meningitis, entzundliche Polyneuritis und Rheumatism us. Ein Beitrag zum Problem Allergie und Nervensystem, Arch Psychiatr Nervenkr, 113, 284, 10.1007/BF02095652 Skilji, 2019, Ophthalmological findings in neuroborreliosis – a prospective study performed in western Sweden, Acta Ophthalmol, 97, 44, 10.1111/aos.13884 Bierman, 2019, Incidence and characteristics of Lyme neuroborreliosis in adult patients with facial palsy in an endemic area in the Netherlands, Epidemiol Infect, 147, e161, 10.1017/S0950268819000438 Ramgopal, 2016, Lyme disease related intracranial hypertension in children: clinical and imaging findings, J Neurol, 263, 500, 10.1007/s00415-015-8007-x Wendling, 2009, Parsonage–Turner syndrome revealing Lyme borreliosis, Joint Bone Spine, 76, 202, 10.1016/j.jbspin.2008.07.013 Lindland, 2018, Imaging in Lyme neuroborreliosis, Insights Imaging, 9, 833, 10.1007/s13244-018-0646-x Kaiser, 2019, Lyme myelopathy: case report and literature review of a rare but treatable disorder, Mult Scler Relat Disord, 29, 1, 10.1016/j.msard.2018.12.034 Pisché, 2017, Subacute parkinsonism as a complication of Lyme disease, J Neurol, 264, 1015, 10.1007/s00415-017-8472-5 Fallon, 1993, Psychiatric manifestations of Lyme borreliosis, J Clin Psychiatry, 54, 263 Garkowski, 2017, Cerebrovascular manifestations of Lyme neuroborreliosis – a systematic review of published cases, Front Neurol, 8, 146, 10.3389/fneur.2017.00146 Kindstrand, 2000, Polyneuropathy in late Lyme borreliosis – a clinical, neurophysiological and morphological description, Acta Neurol Scand, 101, 47, 10.1034/j.1600-0404.2000.00019.x Mygland, 2006, Chronic polyneuropathy and Lyme disease, Eur J Neurol, 13, 1213, 10.1111/j.1468-1331.2006.01395.x Rupprecht, 2018, Diagnostic value of cerebrospinal fluid CXCL13 for acute Lyme neuroborreliosis. A systematic review and meta-analysis, Clin Microbiol Infect, 24, 1234, 10.1016/j.cmi.2018.04.007 Blanc, 2007, Relevance of the antibody index to diagnose Lyme neuroborreliosis among seropositive patients, Neurology, 69, 953, 10.1212/01.wnl.0000269672.17807.e0 Rauer, 2018, Clinical practice guideline: Lyme neuroborreliosis, Dtsch Arztebl Int, 115, 751 Jaulhac, 2019, Lyme borreliosis and other tick-borne diseases. Guidelines from the French scientific societies (II). Biological diagnosis, treatment, persistent symptoms after documented or suspected Lyme borreliosis, Med Mal Infect, 49, 335, 10.1016/j.medmal.2019.05.001 Derscha, 2019, Immunoblot reactivity at follow-up in treated patients with Lyme neuroborreliosis and healthy controls, Ticks Tick Borne Dis, 10, 166, 10.1016/j.ttbdis.2018.09.011 Dersch, 2015, Efficacy and safety of pharmacological treatments for acute Lyme neuroborreliosis — a systematic review, Eur J Neurol, 22, 1249, 10.1111/ene.12744 Wormser, 2006, The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America, Clin Infect Dis, 43, 1089, 10.1086/508667 Koedel, 2015, Lyme neuroborreliosis – epidemiology, diagnosis and management, Nat Rev Neurol, 11, 446, 10.1038/nrneurol.2015.121 Ljøstad, 2010, Remaining complaints one year after treatment for acute Lyme neuroborreliosis; frequency, pattern and risk factors, Eur J Neurol, 17, 118, 10.1111/j.1468-1331.2009.02756.x Dersch, 2016, Prevalence and spectrum of residual symptoms in Lyme neuroborreliosis after pharmacological treatment: a systematic review, J Neurol, 263, 17, 10.1007/s00415-015-7923-0 Feder, 2007, A critical appraisal of “chronic Lyme disease”, N Engl J Med, 357, 1422, 10.1056/NEJMra072023 HAS., 2019